XML 111 R95.htm IDEA: XBRL DOCUMENT v3.20.2
Share-Based Compensation - Summary (Details)
3 Months Ended 6 Months Ended
Feb. 10, 2020
$ / shares
shares
Feb. 11, 2019
$ / shares
shares
Feb. 12, 2018
$ / shares
Jun. 30, 2020
USD ($)
$ / shares
shares
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
installment
$ / shares
shares
Jun. 30, 2019
USD ($)
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Number of shares authorized (shares)       10,400,000   10,400,000  
Share-based compensation cost capitalized as part of real estate assets | $       $ 5,000 $ 27,000 $ 12,000 $ 41,000
Weighted-Average Grant Date Fair Value              
Performance period           3 years  
Vesting rate based on achievement of TSR relative to the NAREIT retail index (as a percent)           33.33%  
Share based Compensation Arrangement by Share based Payment Award Award Vesting Rights Absolute Total Stockholder Return Metrics Percentage           66.66%  
Number of granted annually shares removed as per amendement       200,000   200,000  
Unrecognized compensation cost related to nonvested stock awards | $       $ 2,709,000   $ 2,709,000  
Compensation cost to be recognized over a weighted-average period           2 years 4 months 24 days  
Shares              
Performance period           3 years  
Vested each year for the first two anniversaries after conclusion of performance period              
Weighted-Average Grant Date Fair Value              
Vesting rate           20.00%  
Executive Officer | Maximum              
Weighted-Average Grant Date Fair Value              
Percentage released stock awards granted           1.00%  
Restricted Common Stock              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Share-based compensation expense | $       $ 361,000 546,000 $ 1,505,000 2,259,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]              
Nonvested, beginning of period (shares)           971,846  
Granted (shares)           1,628,397  
Vested (shares)           (1,051,783)  
Forfeited (shares)           (24,911)  
Nonvested, end of period (shares)       1,523,549   1,523,549  
Weighted-Average Grant Date Fair Value              
Weighted average grant-date fair value, nonvested, beginning of period (USD per share) | $ / shares           $ 5.16  
Weighted average grant-date fair value, granted (USD per share) | $ / shares           0.86  
Weighted average grant-date fair value, vested (USD per share) | $ / shares           2.86  
Weighted average grant-date fair value, forfeited (USD per share) | $ / shares           4.64  
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares       $ 2.16   $ 2.16  
Number of annual installment for awards to vest | installment           4  
Shares              
Nonvested, beginning of period (shares)           971,846  
Granted (shares)           1,628,397  
Nonvested, end of period (shares)       1,523,549   1,523,549  
Total fair value of shares vested           1,051,783  
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares       $ 2.16   $ 2.16  
Granted (shares)           1,628,397  
Performance Shares              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]              
Nonvested, beginning of period (shares)           1,766,580  
Granted (shares)           3,408,083  
Vested (shares)           0  
Nonvested, end of period (shares)       5,174,663   5,174,663  
Weighted-Average Grant Date Fair Value              
Weighted average grant-date fair value, nonvested, beginning of period (USD per share) | $ / shares           $ 2.96  
Weighted average grant-date fair value, granted (USD per share) | $ / shares           0.84  
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares $ 0.84 $ 4.74 $ 4.76 $ 1.56   $ 1.56  
Performance period           3 years  
Unrecognized compensation cost related to nonvested stock awards | $       $ 3,597,000   $ 3,597,000  
Shares              
Nonvested, beginning of period (shares)           1,766,580  
Granted (shares)           3,408,083  
Nonvested, end of period (shares)       5,174,663   5,174,663  
Shares granted in period classified as liabilities (shares)           211,375  
Total fair value of shares vested           0  
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares $ 0.84 $ 4.74 $ 4.76 $ 1.56   $ 1.56  
Risk-free interest rate (as a percent) 1.39% 2.54% 2.36%        
Expected share price volatility (as a percent) 57.98% 60.99% 42.02%        
Performance period           3 years  
Granted (shares)           3,408,083  
Performance Shares | Vested each year for the first two anniversaries after conclusion of performance period              
Weighted-Average Grant Date Fair Value              
Vesting rate           20.00%  
Performance Shares | Vested at conclusion of performance period              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Share-based compensation expense | $       $ (60,000) $ 443,000 $ 418,000 $ 869,000
Weighted-Average Grant Date Fair Value              
Vesting rate           60.00%  
Performance Shares | Remaining percentage after performance period              
Weighted-Average Grant Date Fair Value              
Compensation cost to be recognized over a weighted-average period           4 years 2 months 12 days  
Vesting rate           40.00%  
Performance Shares | Chief Executive Officer              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]              
Granted (shares) 2,131,245 357,800          
Weighted-Average Grant Date Fair Value              
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares $ 0.88 $ 2.45          
Shares              
Granted (shares) 2,131,245 357,800          
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares $ 0.88 $ 2.45          
Granted (shares) 2,131,245 357,800          
Performance Shares | Officer              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]              
Granted (shares) 1,065,463 178,875          
Weighted-Average Grant Date Fair Value              
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares $ 0.75 $ 2.29          
Shares              
Granted (shares) 1,065,463 178,875          
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares $ 0.75 $ 2.29          
Granted (shares) 1,065,463 178,875